Should biomarker estimates of HIV incidence be adjusted?

AIDS

Volumn 23, Issue 4, 2009, Pages 485-491

  Brookmeyer, Ron ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

BED; Biomarker; Epidemiology; HIV incidence; Statistics

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ARTICLE; BED ASSAY; DISEASE CLASSIFICATION; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; SEROCONVERSION; STATISTICAL ANALYSIS;

AIDS SERODIAGNOSIS; BIOLOGICAL MARKERS; EPIDEMIOLOGIC METHODS; HIV INFECTIONS; HUMANS;

EID: 62349092045     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283269e28     Document Type: Article

References (15)

1. Lagakos S, Gable A, editors. Methodological challenges in HIV prevention trials. Washington: Institute of Medicine, National Academy Press; 2008.
2. Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross sectional survey using early diagnostic tests. Am J Epidemiol 1995; 141:166-172.
3. Janssen RS, Satten CA, Stramer S, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280:42-48.
4. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, et al. Quantitative detection of increasing HIV Type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002; 18:295-307.
5. Hall IH, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-529.
6. Karon JM, Song R, Brookmeyer R, Kaplan E, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med 2008; 27:4617-4633.
7. UNAIDS Reference Group for Estimates, Modelling and Projections. Statement on the Use of the BED-assay for the Estimation of HIV-1 Incidence for Surveillance or Epidemic Monitoring. Report of a meeting of the UNAIDS Reference Group for Estimates, Modeling and Projections. Athens, Greece, 13-15 December 2005. Geneva: UNAIDS; 2005. http://www.epidem.org/Publications/ BED%20statement.pdf.
8. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, et al. Comparison of HIV-1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006; 22:945-952.
9. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R. Improved HIV-1 incidence estimates using BED capture enzyme immunoassay. AIDS 2008; 22:511-518.
10. Using the BED HIV-1 Capture EIA Assay to estimate incidence using STARHS in the context of surveillance in the United States, October 2007. Centers for Disease Control and Prevention website. http:/www.cdc.gov/hiv/topics/ surveillance/resources/factsheets/BED.htm.
11. Kaplan E, Brookmeyer R. Snapshot estimators of recent HIV incidence. Operat Res 1999; 47:29-37.
12. Brookmeyer R. Accounting for follow-up bias in estimation of Human Immunodeficiency virus incidence rates. J R Stat Soc A 1997; 160:127-140.
13. Cole SR, Chu R, Brookmeyer R. Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data. Am J Epidemiol 2007; 165:94-100.
14. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, et al. Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007; 21:403-408.
15. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, et al. Syndromic management of sexually transmitted infections and behavior change interventions on transmission of HIV-1 in rural Uganda: a community randomized trial. Lancet 2003; 361:645-652.